-
2023-509142-35-00
6
2024-01-29
Atrial fibrillation after stress (e.g., noncardiac surgery or acute me
-
2024-518888-35-00
4
2024-01-24
amyotrophic lateral sclerosis patients
-
2023-503462-23-00
5
2023-12-28
Lung transplant rejection
-
2022-502046-28-00
5
2023-12-22
HER2-Positive, PIK3CA Mutated, Locally Advanced or Metastatic Breast C
-
2022-502775-29-01
5
2023-12-14
Early stage Follicular Lymphoma
-
2023-503224-66-00
5
2023-10-31
Atrial Fibrillation
-
2023-504602-11-00
5
2023-10-25
Mild to moderate Alzheimer's disease
-
2023-510431-11-00
4
2023-07-21
Chronic Lymphocytic Leukemia
-
2022-500587-35-01
5
2023-07-06
Stroke
-
2022-501943-34-00
5
2023-06-27
Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
-
2024-511631-10-00
9
2023-02-27
Hodgkin’s lymphoma
-
2022-500783-35-00
5
2022-12-06
Acute Myeloid Leukemia
-
2024-514139-50-00
5
2022-11-14
Multiple myeloma
-
2023-510240-20-00
4
2022-10-05
Adult Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.
-
2023-504660-41-00
4
2022-07-11
Cholestatic Pruritus in Patients with Primary Biliary Cholangitis (PBC
-
2024-511635-94-00
4
2022-07-11
Relapsed or Refractory Plasmablastic lymphoma
-
2024-510898-24-00
4
2022-01-14
Patients with well differentiated neuroendocrine neoplasia (NENs) not
-
2024-513820-40-00
4
2021-10-29
Metastatic or locally advanced leiomyosarcoma
-
2024-514824-18-00
4
2021-09-16
chronic lymphocytic leukemia/small lymphocytic lymphoma
-
2024-514319-85-00
4
2021-09-14
Advanced rearranged mesenchymal chondrosarcoma
-
2024-515063-66-00
4
2021-03-30
Early stage classical Hodgkin Lymphoma (cHL) without bulky lesions and
-
2023-510515-19-00
5
2020-11-27
Higher-risk-myelodysplastic syndromes
-
2024-519007-10-00
10
2020-10-22
Locally advanced stage II/III rectal cancer
-
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma